<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-145447</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Topical treatments used in superficial cutaneous mycoses</dc:title>
<dc:description xml:lang="en">The topical treatment of superficial cutaneous mycoses includes a series of hygiene measures aimed at avoiding spread of the infection and self-contamination, as well as drug therapy. The present article discusses the mechanisms that patients should develop to prevent dissemination of the infection and accelerate its cure, as well as the indications for exclusively topical treatment. In addition, the main topical antifungal agents currently used (nystatin, imidazoles, allylamines, morpholines and ciclopirox olamine) are reviewed and their mechanism of action, spectrum of activity and presentation are discussed. The various therapeutic schemes used in the topical treatment of cutaneous, oral and genital candidiasis, pityriasis versicolor and some dermatophytoses, specifically tinea corporis, pedia, cruris and manum, onychomycosis and inflammatory tinea are also discussed (AU)</dc:description>
<dc:creator>Gimeno-Carpio, Enrique</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El tratamiento tópico de las micosis cutáneas superficiales comprende una serie de medidas higiénicas, dirigidas a evitar la propagación de la infección y la autocontaminación, además del tratamiento farmacológico. En el presente trabajo se comentan los mecanismos que debe desarrollar el paciente para evitar la diseminación de la infección y acelerar su curación, y las indicaciones del tratamiento exclusivamente tópico. Asimismo, se revisan los principales fármacos antifúngicos tópicos empleados en la actualidad (nistatina, imidazoles, alilaminas, morfolinas y ciclopiroxolamina); se analizan su mecanismo de acción, su espectro de actuación y su presentación. Además, se comentan los diversos esquemas terapéuticos utilizados en el tratamiento tópico de las candidiasis, tanto cutánea como oral y genital, la pitiriasis versicolor y algunas dermatofitosis, en concreto las tineas corporis, pedis, cruris y manum, la onicomicosis y la tiña inflamatoria (AU)</dc:description>
<dc:source>Med. clín (Ed. impr.);126(supl.1): 43-46, ene. 2006. tab</dc:source>
<dc:identifier>ibc-145447</dc:identifier>
<dc:title xml:lang="es">Tratamiento tópico de las micosis cutáneas superficiales</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d30037^s22045</dc:subject>
<dc:subject>^d308^s22044</dc:subject>
<dc:subject>^d308^s22073</dc:subject>
<dc:subject>^d943^s22044</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d943^s22073</dc:subject>
<dc:subject>^d28178^s22073</dc:subject>
<dc:subject>^d28213^s22073</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d287</dc:subject>
<dc:subject>^d14391^s22057</dc:subject>
<dc:subject>^d7274^s22073</dc:subject>
<dc:subject>^d2209^s22057</dc:subject>
<dc:subject>^d502^s22073</dc:subject>
<dc:subject>^d9373^s22057</dc:subject>
<dc:type>article</dc:type>
<dc:date>200601</dc:date>
</metadata>
</record>
</ibecs-document>
